Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Molecular & Cellular Proteomics : MCP|August 7, 2024
optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input MaterialMogjiborahman Salek, Jonas D Förster, Jonas P Becker, et al.Oncoimmunology|September 22, 2025
A versatile silica nanoparticle platform for induction of T cell responses - applied for therapeutic vaccination against HPV16 E6/E7-positive tumors in MHC-humanized miceSebastian Kruse, Lia T Fricke, Samantha Zottnick, et al.Science Translational Medicine|November 15, 2023
Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancerZibo Meng, Aaron Rodriguez Ehrenfried, Chin Leng Tan, et al.Nature Communications|August 27, 2025
Upstream open reading frame translation enhances immunogenic peptide presentation in mitotically arrested cancer cellsAlexander Kowar, Jonas P Becker, Rossella Del Pizzo, et al.Plos Pathogens|December 16, 2016
Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine VectorsIryna Dekhtiarenko, Robert B Ratts, Renata Blatnik, et al.Frontiers in Immunology|January 19, 2024
MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detectionMarten Meyer, Christina Parpoulas, Titouan Barthélémy, et al.Science Advances|April 10, 2026
Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoireHannes Kehm, Stefan Zens, Daniel Baumann, et al.Nature|July 22, 2014
A vaccine targeting mutant IDH1 induces antitumour immunityTheresa Schumacher, Lukas Bunse, Stefan Pusch, et al.Vaccine|July 14, 2024
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancerPeter M Dull, Sharon L Achilles, Rafi Ahmed, et al.Nature Communications|February 1, 2025
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigenYu-Chan Chih, Amelie C Dietsch, Philipp Koopmann, et al.Pageof 7